TiGenix

TiGenix

Year of investment: 2009

TiGenix is a late-stage regenerative medicine company active in tissue engineering (cartilage repair) and allogeneic cell therapy. It has a marketing agreement with Sobi AB for its ChrondroCelect product in Europe. Its cell therapy products are in advanced stages of clinical trials. TiGenix NV is listed at Euronext Brussels.